Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception-Reference-Cited by-同舟云学术

Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception

Published:2014-07-31 Issue:12 Volume:28 Page:1825-1830
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Murnane Pamela M.,Heffron Renee,Ronald Allan,Bukusi Elizabeth A.,Donnell Deborah,Mugo Nelly R.,Were Edwin,Mujugira Andrew,Kiarie James,Celum Connie,Baeten Jared M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference11 articles.

1. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.;Heffron;Lancet Infect Dis,2012

2. Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence.;Polis;Lancet Infect Dis,2013

3. Preexposure prophylaxis for HIV infection among African women.;Van Damme;N Engl J Med,2012

4. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.;Kearney;Pharmacotherapy,2009

5. Tenofovir use and pregnancy among women initiating HAART.;Maskew;AIDS,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis of Pregnancy Events in Biomedical HIV Prevention Trials in Sub-Saharan Africa: Implications for Gender Transformative Trials;AIDS and Behavior;2024-08-17

2. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024;MMWR. Recommendations and Reports;2024-08-08

3. Adherence to Oral Pre-Exposure Prophylaxis Intervention by Transgender Women: A Systematic Review;AIDS Education and Prevention;2023-10

4. Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention;Frontiers in Immunology;2022-12-06

5. Safety of oral tenofovir disoproxil - emtricitabine for HIV preexposure prophylaxis in adults;Current Opinion in HIV and AIDS;2022-07